Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Dowden Nathan J
President & COO at Entrada Therapeutics. Filing since 27 Jun 2022.
CIK 0001873392
Company
Date
Role
Action
Shares
Amount
Of holding
TRDA
Entrada Therapeutics, Inc.
4 May 2026
President & COO
Sold on a plan
15,000
$229.95K
7.0%
TRDA
Entrada Therapeutics, Inc.
10 Mar 2026
President & COO
Sold on a plan
11,894
$155.19K
5.7%
TRDA
Entrada Therapeutics, Inc.
9 Mar 2026
President & COO
Sold on a plan
3,116
$40.58K
1.5%
TRDA
Entrada Therapeutics, Inc.
26 Sep 2024
President & COO
Sold on a plan
847
$13.55K
0.7%
TRDA
Entrada Therapeutics, Inc.
9 Sep 2024
President & COO
Sold on a plan
1,904
$28.69K
1.5%
TRDA
Entrada Therapeutics, Inc.
6 Sep 2024
President & COO
Sold on a plan
399
$6.06K
0.3%
TRDA
Entrada Therapeutics, Inc.
16 Aug 2024
President & COO
Sold on a plan
27,097
$440.80K
17.2%
TRDA
Entrada Therapeutics, Inc.
6 Mar 2024
President & COO
Sold on a plan
1,826
$22.50K
1.3%
TRDA
Entrada Therapeutics, Inc.
6 Sep 2023
Chief Operating Officer
Sold on a plan
972
$13.09K
2.0%
TRDA
Entrada Therapeutics, Inc.
11 Jul 2023
Chief Operating Officer
Sold on a plan
3,897
$70.33K
9.9%
TRDA
Entrada Therapeutics, Inc.
10 Jul 2023
Chief Operating Officer
Sold on a plan
3,200
$57.61K
7.5%
TRDA
Entrada Therapeutics, Inc.
22 Jun 2023
Chief Operating Officer
Sold on a plan
7,097
$113.70K
14.3%
TRDA
Entrada Therapeutics, Inc.
20 Jun 2023
Chief Operating Officer
Sold on a plan
8,885
$132.70K
15.2%
TRDA
Entrada Therapeutics, Inc.
31 Oct 2022
Chief Operating Officer
Sold, plan not stated
2,100
$50.50K
4.4%
TRDA
Entrada Therapeutics, Inc.
25 Oct 2022
Chief Operating Officer
Sold, plan not stated
9,348
$194.19K
16.5%
TRDA
Entrada Therapeutics, Inc.
24 Oct 2022
Chief Operating Officer
Sold, plan not stated
2,404
$46.40K
4.1%
TRDA
Entrada Therapeutics, Inc.
21 Oct 2022
Chief Operating Officer
Sold, plan not stated
2,771
$50.67K
4.5%
TRDA
Entrada Therapeutics, Inc.
20 Oct 2022
Chief Operating Officer
Sold, plan not stated
905
$16.36K
1.4%
TRDA
Entrada Therapeutics, Inc.
26 Sep 2022
Chief Operating Officer
Sold, plan not stated
1,544
$23.85K
2.4%
TRDA
Entrada Therapeutics, Inc.
23 Sep 2022
Chief Operating Officer
Sold, plan not stated
1,018
$15.34K
1.6%
TRDA
Entrada Therapeutics, Inc.
21 Sep 2022
Chief Operating Officer
Sold, plan not stated
3,275
$49.54K
4.8%
TRDA
Entrada Therapeutics, Inc.
15 Sep 2022
Chief Operating Officer
Sold, plan not stated
100
$1.50K
0.1%
TRDA
Entrada Therapeutics, Inc.
9 Sep 2022
Chief Operating Officer
Sold, plan not stated
865
$13.03K
1.2%
TRDA
Entrada Therapeutics, Inc.
8 Sep 2022
Chief Operating Officer
Sold, plan not stated
912
$13.81K
1.3%
TRDA
Entrada Therapeutics, Inc.
27 Jun 2022
Chief Operating Officer
Sold, plan not stated
7,714
$100.28K
10.6%
25 decisions on file.
